» Articles » PMID: 28303539

P53 Induction and Cell Viability Modulation by Genotoxic Individual Chemicals and Mixtures

Overview
Publisher Springer
Date 2017 Mar 18
PMID 28303539
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of the p53 tumor suppression protein to DNA response elements after genotoxic stress can be quantified by cell-based reporter gene assays as a DNA damage endpoint. Currently, bioassay evaluation of environmental samples requires further knowledge on p53 induction by chemical mixtures and on cytotoxicity interference with p53 induction analysis for proper interpretation of results. We investigated the effects of genotoxic pharmaceuticals (actinomycin D, cyclophosphamide) and nitroaromatic compounds (4-nitroquinoline 1-oxide, 3-nitrobenzanthrone) on p53 induction and cell viability using a reporter gene and a colorimetric assay, respectively. Individual exposures were conducted in the absence or presence of metabolic activation system, while binary and tertiary mixtures were tested in its absence only. Cell viability reduction tended to present direct correlation with p53 induction, and induction peaks occurred mainly at chemical concentrations causing cell viability below 80%. Mixtures presented in general good agreement between predicted and measured p53 induction factors at lower concentrations, while higher chemical concentrations gave lower values than expected. Cytotoxicity evaluation supported the selection of concentration ranges for the p53 assay and the interpretation of its results. The often used 80% viability threshold as a basis to select the maximum test concentration for cell-based assays was not adequate for p53 induction assessment. Instead, concentrations causing up to 50% cell viability reduction should be evaluated in order to identify the lowest observed effect concentration and peak values following meaningful p53 induction.

Citing Articles

In Vitro Metabolism and p53 Activation of Genotoxic Chemicals: Abiotic CYP Enzyme vs Liver Microsomes.

Henneberger L, Huchthausen J, Braasch J, Konig M, Escher B Chem Res Toxicol. 2024; 37(8):1364-1373.

PMID: 38900731 PMC: 11337206. DOI: 10.1021/acs.chemrestox.4c00101.


Multi-Omics Reveal Additive Cytotoxicity Effects of Aflatoxin B1 and Aflatoxin M1 toward Intestinal NCM460 Cells.

Gao Y, Yang X, Wang J, Liu H, Zheng N Toxins (Basel). 2022; 14(6).

PMID: 35737029 PMC: 9231300. DOI: 10.3390/toxins14060368.


Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers.

Adeluola A, Bosomtwe N, Long T, Amin A Apoptosis. 2022; 27(5-6):342-353.

PMID: 35267106 PMC: 9133209. DOI: 10.1007/s10495-022-01720-5.


Exposure of Toluene Diisocyanate Induces DUSP6 and p53 through Activation of TRPA1 Receptor.

Kim S, Kim M, Sung J Int J Mol Sci. 2022; 23(1).

PMID: 35008945 PMC: 8745568. DOI: 10.3390/ijms23010517.


Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells.

Pruteanu L, Kopanitsa L, Modos D, Kletnieks E, Samarova E, Bender A PLoS One. 2020; 15(9):e0239551.

PMID: 32946518 PMC: 7500592. DOI: 10.1371/journal.pone.0239551.


References
1.
Steger-Hartmann T, Kummerer K, Hartmann A . Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol Environ Saf. 1997; 36(2):174-9. DOI: 10.1006/eesa.1996.1506. View

2.
Bensaad K, Rouillard D, Soussi T . Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line. Oncogene. 2001; 20(29):3766-75. DOI: 10.1038/sj.onc.1204492. View

3.
Arlt V, Cole K, Phillips D . Activation of 3-nitrobenzanthrone and its metabolites to DNA-damaging species in human B lymphoblastoid MCL-5 cells. Mutagenesis. 2004; 19(2):149-56. DOI: 10.1093/mutage/geh008. View

4.
Bhaskaran A, May D, Rand-Weaver M, Tyler C . Fish p53 as a possible biomarker for genotoxins in the aquatic environment. Environ Mol Mutagen. 1999; 33(3):177-84. View

5.
Kester H, Sonneveld E, van der Saag P, van der Burg B . Prolonged progestin treatment induces the promoter of CDK inhibitor p21 Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells. Exp Cell Res. 2003; 284(2):264-73. DOI: 10.1016/s0014-4827(02)00017-4. View